Figure 6
From: The potential prognostic value of connexin 26 and 46 expression in neoadjuvant-treated breast cancer
Kaplan-Meier plot of overall survival based on Cx46 expression pre- and post- chemotherapy according to the morphological response rate assessed using the EWGBSP TR2b, Sataloff TB and Miller-Payne G3 classifications. Elevated Cx46 expression both pre- and post-chemotherapy is associated with significantly better (p=0.002-0.05) overall survival in all of these categories.